Summary of "جلسه دوم فارماکولوژی قسمت دوم"

Summary of "جلسه دوم فارماکولوژی قسمت دوم" (Pharmacology Session 2, Part 2)

This video lecture focuses on Pharmacodynamics, the study of how drugs affect living organisms, emphasizing drug-receptor interactions and different receptor types. It also explains key pharmacological concepts such as affinity, efficacy, potency, agonists, antagonists, and types of antagonism.

Main Ideas and Concepts

1. Pharmacodynamics Overview

Pharmacodynamics refers to the effects drugs have on the body after administration.
These effects are explained primarily through the interaction between drugs and receptors.
Other interactions include drug-enzyme interactions and non-specific drug interactions, but the focus here is on drug-receptor interactions.

2. Receptors

Receptors are mainly proteins located on or inside target cells where drugs exert their effects.
They serve as binding sites for drugs (ligands).
Binding triggers biochemical processes leading to drug effects.
Receptors are regulatory proteins that initiate cellular responses upon binding with drugs or hormones.

3. Types of Receptors

Ion Channel Receptors - Ligand binding opens ion channels, allowing ions to enter the cell, causing hyperpolarization or depolarization. - Examples of endogenous ligands: GABA, glycine, aspartate, acetyl serotonin. - Illustrated by a receptor with a binding site where the drug binds, causing channel opening.
G Protein-Coupled Receptors (GPCRs) - Drugs bind to receptors linked to G proteins. - Activation leads to enzyme activity changes inside the cell, converting ATP to ADP and GTP to GDP. - This triggers secondary messengers (e.g., calcium release, protein phosphorylation). - Examples: ACTH, angiotensin, FSH, glucagon, histamine, serotonin, vasopressin.
Enzyme-Linked Receptors - Receptors with enzymatic activity, located on the cell membrane. - Drug binding activates intracellular enzymatic pathways. - Examples: insulin receptors, EGFR (epidermal growth factor receptor), erythropoietin receptors.
Cytosolic/Nuclear Receptors - Located inside the cytoplasm or nucleus. - Bind fat-soluble drugs that cross cell membranes. - Binding affects gene transcription and protein synthesis, leading to cellular responses.

4. Key Pharmacological Terms

Affinity: The ability of a drug to bind to its receptor via ionic, hydrogen, or covalent bonds.
Efficacy: The ability of a drug to produce a response after binding.
Potency: The dose of a drug required to produce a specific effect.
Intrinsic Activity: The inherent ability of a compound to produce an effect; compounds lacking this are not considered drugs.

5. Agonists and Antagonists

Agonists: Bind to receptors and produce a biological effect (have both affinity and efficacy).
Antagonists: Bind to receptors but block or oppose the effect of agonists (have affinity but no efficacy).

Types of Antagonists:

Competitive Antagonists: Compete with agonists for the same receptor binding site.
Non-Competitive Antagonists: Bind to different sites on the receptor, not competing directly with agonists.
Partial Agonists/Antagonists: Produce weaker effects than full agonists or antagonists.

Antagonism Types:

Pharmacological Antagonism: Two drugs act on the same receptor producing opposite effects (e.g., Propranolol vs. norepinephrine on beta receptors).
Physiological Antagonism: Two drugs act on different receptors but produce opposite physiological effects (e.g., epinephrine increases blood pressure via beta receptors, histamine decreases it via histamine receptors).
Chemical Antagonism: Drugs interact chemically without involving receptors, neutralizing each other’s effects (e.g., Dimercaprol chelates heavy metals, aluminum hydroxide neutralizes stomach acid).

Detailed Bullet Point Summary

Pharmacodynamics: Study of drug effects on the body.
Receptors: Protein molecules on/in cells; drug binding sites.
Receptor Types:
- Ion Channel Receptors: Ligand binding opens channels → ion flow → cellular effects.
- G Protein-Coupled Receptors: Drug binding activates enzymes → secondary messengers → cellular response.
- Enzyme-Linked Receptors: Drug binding activates enzymatic activity → signaling pathways.
- Cytosolic/Nuclear Receptors: Fat-soluble drugs enter cells → bind receptors → gene transcription → protein synthesis.
Pharmacological Definitions:
- Affinity = ability to bind receptor.
- Efficacy = ability to cause response.
- Potency = dose required.